An Assessment of the Relationship between Structural and Functional Imaging of Cerebrovascular Disease and Cognition-Related Fibers

Table 2

Comparison of TVW, AIS, VFT, and TMT in the VaD, VCIND, and NCI patients ( ± s).

Group	Treatment time	TVW	AIS	VFT	TMT
VaD (n = 40)	Before treatment	0.96 ± 0.23	1.52 ± 0.49	10.27 ± 3.17	123.63 ± 57.73
	After 6 months of treatment	0.93 ± 0.21	1.36 ± 0.38	12.46 ± 2.19	122.15 ± 45.38
	After 12 months of treatment	0.84 ± 0.19	1.63 ± 0.11	15.13 ± 2.14	120.77 ± 54.69
VCIND (n = 40)	Before treatment	0.91 ± 0.22	1.68 ± 0.39	11.14 ± 3.12	123.55 ± 56.87
	After 6 months of treatment	0.88 ± 0.21	1.57 ± 0.27	13.03 ± 2.06	121.89 ± 45.44
	After 12 months of treatment	0.82 ± 0.18	1.21 ± 0.63	16.44 ± 2.16	120.32 ± 54.76
NCI (n = 40)	Before treatment	0.80 ± 0.19	1.79 ± 0.41	15.03 ± 3.06	123.46 ± 46.35
	After 6 months of treatment	0.81 ± 0.17	1.80 ± 0.24	15.75 ± 2.04	115.57 ± 55.01
	After 12 months of treatment	0.79 ± 0.16	1.87 ± 0.36	16.72 ± 2.13	111.47 ± 45.32
F/ VaD group value		0.163/0.028	0.325/0.003	0.754/0.003	0.855/0.016
F/ VCIND group value		0.174/0.005	0.542/0.018	0.584/0.027	0.585/0.027
F/ NCI group value		0.164/0.002	0.234/0.003	0.234/0.015	0.584/0.005
t/ 6 months treatment group value		0.471/0.013	0.422/0.014	0.742/0.003	0.234/0.023
t/ 12 months treatment group value		0.315/0.001	0.512/0.032	0.284/0.002	0.679/0.015